Theravance Biopharma, Inc. (TBPH)
19.07
+0.01
(+0.05%)
USD |
NASDAQ |
Feb 25, 16:00
19.17
+0.10
(+0.52%)
After-Hours: 18:33
Theravance Biopharma Shareholders Equity (Annual) : 175.54M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Corcept Therapeutics, Inc. | 679.59M |
| Nektar Therapeutics | 60.74M |
| Innoviva, Inc. | 691.16M |
| Oramed Pharmaceuticals, Inc. | 146.26M |
| Moderna, Inc. | 8.65B |